COMPASS Pathways plc (CMPS)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Kabir Kumar Nath M.A., M.B.A.
|
CEO & Executive Director | 1.07M | -- | 1964 |
|
Ms. Teri Loxam M.B.A.
|
Chief Financial Officer | 734.15k | -- | 1973 |
|
Dr. Guy Goodwin
|
Chief Medical Officer | 632.41k | -- | 1948 |
|
Mr. Stephen D. Schultz
|
Senior Vice President of Investor Relations | -- | -- | -- |
|
Ms. Kelley Boucher
|
Chief People Officer | -- | -- | -- |
|
Mr. Lars Christian Wilde
|
Senior Advisor | -- | -- | 1986 |
|
Dr. Susan C. Stansfield Ph.D.
|
Advisor | -- | -- | -- |
|
Dr. Michael Gold M.D., M.Sc.
|
Chief Research & Development Officer | -- | -- | 1961 |
|
Ms. Lori Englebert M.B.A.
|
Chief Commercial Officer | -- | -- | 1978 |
|
Dr. Steve Levine M.D.
|
Chief Patient Officer | -- | -- | -- |
COMPASS Pathways plc
- Sector:
- Healthcare
- Industry: Medical Care Facilities
- Full Time Employees:
- 156
Description
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Corporate Governance
Upcoming Events
November 3, 2026 at 12:30 PM UTC
COMPASS Pathways plc Earnings Date
